Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor

Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor 1 first-author 1 1 1 1 1 1 1 2 corresp ‡Corresponding Author ‡Corresponding Author †E-mail:hongbu@scu.edu.cn †E-mail:hongbu@scu.edu.cn hongbu@scu.edu.cn Key Laboratory of Transplant Engineering and Immunology of Ministry of Health, West China Hospital, Sichuan University, Chengdu 610041, China Key Laboratory of Transplant Engineering and Immunology of Ministry of Health, West China Hospital, Sichuan University, Chengdu 610041, China Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China Objective: 2 Large segmental bone defect repair remains a clinical and scientific challenge with increasing interest focusing on combining gene transfection with tissue engineering techniques. The aim of this study is to investigate the effect of connective tissue growth factor (CTGF) on the proliferation and osteogenic differentiation of the bone marrow mesenchymal stem cells (MSCs). Methods: 2 A CTGF-expressing plasmid (pCTGF) was constructed and transfected into MSCs. Then expressions of bone morphogenesis-related genes, proliferation rate, alkaline phosphatase activity, and mineralization were examined to evaluate the osteogenic potential of the CTGF gene-modified MSCs. Results: 2 Overexpression of CTGF was confirmed in pCTGF-MSCs. pCTGF transfection significantly enhanced the proliferation rates of pCTGF-MSCs ( P < 0.05). CTGF induced a 7.5-fold increase in cell migration over control ( P < 0.05). pCTGF transfection enhanced the expression of bone matrix proteins, such as bone sialoprotein, osteocalcin, and collagen type I in MSCs. The levels of alkaline phosphatase (ALP) activities of pCTGF-MSCs at the 1st and 2nd weeks were 4.0- and 3.0-fold higher than those of MSCs cultured in OS-medium, significantly higher than those of mock-MSCs and normal control MSCs ( P < 0.05). Overexpression of CTGF in MSCs enhanced the capability to form mineralized nodules. Conclusion: 2 Overexpression of CTGF could improve the osteogenic differentiation ability of MSCs, and the CTGF gene-modified MSCs are potential as novel cell resources of bone tissue engineering. Mesenchymal stem cells (MSCs) Connective tissue growth factor (CTGF) Osteogenic differentiation Osteoblasts Overexpression Gene modification INTRODUCTION 1 Reconstruction of large skeletal defects is still a challenge for orthopaedic, oral and maxillofacial surgeons. Regeneration with either autograft or allograft provides excellent results, but it is limited by donor-site morbidity and supply. Bone tissue engineering might be a novel way to solve these problems (Rose and Oreffo, 2002 2002 ; Kofron and Laurencin, 2006 2006 ; Kanczler and Oreffo, 2008 2008 ). Based on the principle of bone tissue engineering, seeding cells, scaffolds, and signaling molecules are administered, individually or in combination, to regenerate new bone. Mesenchymal stem cells (MSCs), for both self renewal and being multipotent, have been regarded as the most hopeful cell sources for bone tissue engineering and regenerative medicine (Abreu et al., 2002 2002 ; Howard et al., 2008 2008 ; Slater et al., 2008 2008 ; Xiang et al., 2007 2007 ). To enhance the proliferation and orientational differentiation ability of stem cells by gene modification is hot in bone tissue engineering (Mauney et al., 2005 2005 ; Goessler et al., 2006 2006 ; Meijer et al., 2007 2007 ). Bone marrow MSCs are attractive in bone tissue engineering, for it can be easily isolated and further modified by gene modification (Pelled et al., 2002 2002 ; Pountos et al., 2007 2007 ; Slater et al., 2008 2008 ). Many genes had been regulated or overexpressed in MSCs to improve their ability of differentiation into osteoblastic cells. These genes include Runx2, bone morphogenetic protein, fibroblastic growth factor-2 (FGF-2), and so on. Connective tissue growth factor (CTGF) is a secreted, extracellular matrix-associated signaling molecule that belongs to the CCN (CTGF, Cyr61/Cef10, and Nov) family (Nishida et al., 2007 2007 ; Luft, 2008 2008 ; Yamanaka et al., 2008 2008 ). The CCN family of proteins is composed of several cysteine rich proteins with diverse functions including regulation of angiogenesis, cell adhesion, proliferation, skeletal development, tooth development, and apoptosis (Brigstock, 2003 2003 ; Perbal et al., 2003 2003 ; Rachfal and Brigstock, 2005 2005 ). CTGF has mitogenic and chemotactic activities, and also stimulates synthesis of extracellular matrix components. CTGF is capable of promoting both the growth and the differentiation of most mesenchymal cells involved in endochondral ossification. This indicates that CTGF acts as a central driver in cartilage/bone growth and regeneration (Heng et al., 2006 2006 ; Kanaan et al., 2006 2006 ; Kubota and Takigawa, 2007 2007 ; Ono et al., 2007 2007 ). The importance of CTGF in skeletal development is demonstrated with the generation of CTGF knockout mice (Yamaai et al., 2005 2005 ). CTGF ablation results in mice with misshappened skeleton, craniofacial abnormalities, and defects associated with endochondral ossification, and attributes to defects in cell proliferation, matrix formation, and remodeling during endochondral ossification. Growing evidence indicates that CTGF plays an essential role in the differentiation of osteoblasts and bone formation. However, little attention has been paid to the effect of CTGF on the proliferation and differentiation of MSCs. In this paper, we modified MSCs by transfection of a plasmid containing the full length of human CTGF cDNA, and further investigated the proliferation and differentiation of CTGF gene-modified MSCs. MATERIALS AND METHODS 1 Isolation and culture of MSCs 2 The human MSCs were isolated and cultured as previously described (Lee et al., 2003 2003 ; Duan et al., 2008 2008 ; Jiang et al., 2008 2008 ). Briefly, bone marrow was harvested from proximal femur samples removed during hip replacement surgery with the consent of patients and the approval by local Ethical Committee. Bone mononuclear cells (MNCs) were isolated from bone marrow aspirates by Percoll-gradient centrifugation and plated at 2×10 5 cells/cm 2 in T-75 culture flasks. The non-adhered cells were removed after 24~48 h incubated at 37 °C in 5% CO 2 atmosphere and adherent cells were further cultured. Upon 80% confluence, adherent cells were detached by 0.2% (w/v) trypsin-0.02% (v/v) ethylenediamine tetraacetic acid (EDTA, Sigma, USA), and then seeded at 8×10 3 cells/cm 2 into T-75 flask. Cells used in subsequent experiments were between the 3rd and 7th passages. MSCs were confirmed by adipogenic, chondrogenic, and osteogenic differentiation assays (Caterson et al., 2002 2002 ; Beyer Nardi and da Silva Meirelles, 2006 2006 ). Briefly, osteogenic differentiation was induced by culturing MSCs monolayer in osteogenic (OS) medium containing 10 mmol/L β-glycerol phosphate, 10 −8 mol/L dexamethasone, and 50 mg/L ascorbic acid 2-phosphate. Mineralization was evaluated by alkaline phosphatase (ALP) staining and von Kossa staining. For chondrogenic differentiation, MSCs were centrifuged at 800× g for 5 min and cultured in the chondrogenic inductive medium (high-glucose Dulbecco’s Modified Eagle’s Medium (DMEM), 1% (v/v) ITS+ (insulin, transferrin, selenious acid, plus linoleic acid and bovine serum albumin), 10 −6 mol/L dexamethasone, 35 μg/ml praline, 0.17 mmol/L ascorbic acid 2-phosphate, and 5 ng/ml transforming growth factor-β1 (TGF-β1) for 21 d. Then frozen sections were obtained and immunostained for type II collagen. Adipogenic differentiation was induced by culturing MSCs monolayer in the adipogenic inductive medium (high-glucose DMEM, 0.5 mmol/L 3-isobutyl-1-methylxanthine, 10 −6 mol/L dexamethasone, 100 μg/ml indomethacin, and 10 μg/ml insulin) for 21 d. Adipogenic induction was confirmed by oil red O staining. Construction of CTGF-expressing vector 2 Plasmids containing full-length human CTGF cDNA were kindly provided by Prof. Tong-chuan He, Molecular Oncology Laboratory, University of Chicago Medical Center, USA. The full-length CTGF cDNA fragment was excised from the plasmid by digesting with restriction endonucleases, and then subcloned into Hin dIII/ Xho I sites of pcDNA3.1(+) vector (Invitrogen, USA). The plasmid was confirmed by polymerase chain reaction (PCR), restriction endonucleases digestion, and DNA sequence. The resulting plasmid was named after pcDNA3.1-CTGF (pCTGF) containing the full-length of human CTGF cDNA fragment under the control of the cytomegalovirus (CMV) promoter. Plasmid transfection 2 For plasmid transfection, MSCs were plated in six-well plates at a density of 2.5×10 5 cells/well. Transfection of MSCs was performed using Lipofectamine-2000 (Invitrogen, USA) according to the protocol provided by the manufacturer. Briefly, 2 μg purified pCTGF diluted in 100 μl of serum-free medium was mixed with 4 μg Lipofectamine-2000 diluted in 100 μl of serum-free medium. The DNA-Lipofectamine-2000 mixture was incubated for 30 min at room temperature. Then 800 μl of cell growth medium without fetal calf serum (FCS) was added into the mixed solution. When the cells reached 70% confluence, they were washed with serum-free growth medium, and the transfection solution was added. After incubated at 37 °C for 5 h, the transfection solution was replaced with normal cell growth medium. After 24 h, the cells were passaged and subjected to G418 (500 μg/ml) selection for 2 weeks (pCTGF-MSCs). Control cells were mock transfected with “empty” vector (mock-MSCs). The expression of CTGF was detected by Western blotting and real time PCR. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting 2 Culture supernatant was collected and precipitated with 10% (v/v) trichloroacetic acid (TCA). The proteins in the supernatant were then electrophoresed on 12% (v/v) SDS-PAGE. The separated proteins were transferred electrophoretically onto a polyvinylidene fluoride (PVDF) membrane using a semidry blotting apparatus (Multiphor II, Pharmacia Biotech, USA). Then the membrane was blocked with a Tris-buffered saline (TBS) solution containing 2% (w/v) skim milk at 37 °C for 5 h. Then the membrane was incubated with mouse anti-human CTGF monoclonal antibody (R&D, USA) diluted (1:500, v/v) in TBS-Tween 20 (TBST) solution containing 2% (w/v) skim milk at room temperature for 2 h. The membrane was washed 3 times with TBST solution and then incubated with horseradish peroxidase (HRP)-conjugated rabbit anti-human IgG diluted (1:2000, v/v) into TBST solution containing 2% (w/v) skim milk at 37 °C for 90 min. After washed by TBST solution, protein bands were visualized by the electrochemiluminescence (ECL) kit (Amersham Pharmacia Biotech, UK). Cell proliferation assay 2 Cells were seeded into 96-well microplates at a density of 1×10 3 cells/well. During the continuous 7 d, cell proliferation was measured by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay every day. Briefly, 20 μl MTT (5 mg/ml) was added to each well and the microplate was further incubated at 37 °C for 4 h. After the supernatant was removed, 200 μl dimethyl sulfoxide (DMSO) was added into each well and the absorbance was examined by using an HTS 7000 Plus Bio Assay Reader (PerkinElmer Life Sciences, USA) at the wavelength of 570 nm. Migration assay 2 The effect of CTGF on cell migration was measured by using transwell chamber described previously (Karp et al., 2005 2005 ). In brief, identical numbers of untransfected MSCs, mock-MSCs or pCTGF-MSCs were plated into the bottom chamber of 12-transwell culture plates (Corning Costar, Cambridge, USA) individually. And about 2×10 4 cells of the untransfected MSCs were seeded into the upper chamber of transwell, which consists of collagencoated microporous membrane (8.0 μm). Then the plate containing transwells was placed back to the incubator. After incubated for 4 h, the upper chamber of the transwell was taken out and the unattached cells on the underside of the membrane were wiped by a damp cotton swab. The cells on the underside of the membrane were fixed in 10% (v/v) phosphate-buffered formalin for 10 min and stained with hematoxylin for 30 min. The stained membrane was then mounted onto a glass slide with Permount (Fisher Scientific, Pittsburgh, PA) and dried. The migrating cells were then observed under microscope and the cell number was counted from 10 random fields with 200× magnifications. The transwell assays were performed in duplicate under each experimental condition. Quantitative real-time PCR analysis for the expressions of bone-related genes 2 Cells were washed twice in phosphate buffered saline (PBS), and total RNA of normal control MSCs, mock-MSCs, and pCTGF-MSCs was isolated on Days 3 and 14 after transfection by using TRIZOL Reagent (Invitrogen Life Technologies, NY, USA). Total RNA of MSCs induced by OS-medium was also extracted on Days 3 and 14 after induction. The concentration of extracted RNA was quantified by spectrophotometer (GeneQuant Pro; Amersham Biosciences, USA) at wavelengths of 260 and 280 nm. The quality of RNA was determined by agarose gel electrophoresis. Total RNA was reversely transcribed into first-strand cDNA by using the TaKaRa reverse transcriptase (RT)-PCR Kit (TaKaRa Bio. Inc., Shiga, Japan). The first-strand cDNA products were used as templates. The expressions of bone-related genes were determined by SYBR green-based real-time PCR analysis using TaKaRa PrimeScript™ RT Regent Kit (TaKaRa Bio. Inc.). Each reaction contained 12.5 μl 2× SYBR Premix Ex Taq™, 1 μl forward primer, 1 μl reverse primer, 2 μl cDNA template, and ddH 2 O to a final volume of 25 μl per reaction. The sample was analyzed on the Bio-Rad iCycler iQ™ Multicolor Real-Time Detection System (Bio-Rad Laboratories Inc., Richmond, California, USA), while the RT-PCR was performed and fluorescence signal was detected simultaneously. The specific primers were displayed in Table 1 1 . The PCR was performed as followings: denatured at 95 °C for 2 min at the beginning, then denatured at 95 °C for 5 s, annealing at 55~57 °C for 30 s, and extending at 72 °C for 20 s, for 30 cycles. The specificity of real-time PCR was verified by melting curve analysis (55~95 °C, with 0.5 °C increment each cycle), and further confirmed by resolving the PCR products on 1.5% (w/v) agarose gels. The baseline cycles and the threshold were automatically calculated by Bio-Rad iCycler software. In order to quantify the expression of each gene, standard curves were constructed using the purified, gradient diluted relevant PCR product. Gene expression was normalized by the expression of house keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the same sample. The data represented the average fold changes with standard deviation. All experiments were carried out in triplicate. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; ColIα1: collagen type I α1; AKP2: alkaline phosphatase 2; IBSP: integrin-binding sialoprotein; Runx2: Runt-related transcription factor 2; OCN: osteocalcin Gene Primer Annealing temperature (°C) GenBank No. GAPDH Forward: 5′-TGTGTCCGTCGTGGATCTGA-3′ 57.4 NM_001001303 Reverse: 5′-TTGCTGTTGAAGTCGCAGGAG-3′ 57.8 AKP2 Forward: 5′-TGCCTACTTGTGTGGCGTGAA-3′ 57.8 NM_007432 Reverse: 5′-TCACCCGAGTGGTAGTCACAATG-3′ 60.2 ColIα1 Forward: 5′-ATGCCGCGACCTCAAGATG-3′ 57.1 NM_007742 Reverse: 5′-TGAGGCACAGACGGCTGAGTA-3′ 59.8 IBSP Forward: 5′-TGGAGACTGCGATAGTTCCGAAG-3′ 60.2 NM_008318 Reverse: 5′-CGTAGCTAGCTGTTACACCCGAGAG-3′ 63.9 Runx2 Forward: 5′-CACTGGCGGTGCAACAAGA-3′ 57.1 NM_009821 Reverse: 5′-TTTCATAACAGCGGAGGCATTTC-3′ 56.6 OCN Forward: 5′-CCCTCTCTCTGCTCACTCTGCT-3′ 61.9 L24430 Reverse: 5′-TGTGTTGTCCCTTCCCCTCT-3′ 57.4 Immunohistochemistry 2 Immunohistochemical analysis was carried out as described previously (Lin et al., 2005 2005 ). In brief, MSCs on the slides were fixed with 4% (v/v) buffered paraformaldehyde. After blocking of endogenous peroxidase activity with 3% (v/v) hydrogen peroxide in methanol for 30 min, the slides were washed with PBS, and non-specific binding was blocked with 1% (w/v) bovine serum albumin and 1.5% (w/v) normal goat serum at room temperature for 30 min. Slides were subsequently incubated with goat polyclonal antibody against osteocalcin (OCN) (Santa Cruz, USA) at 4 °C overnight. After washed with PBS, slides were incubated with the secondary biotinylated antibodies and HRP-conjugated streptavidin to detect the primary antibody. Staining was done with 3,3′-diaminobenzidine tetrahydrochloride (DAB) as chromogens and counter staining was performed in Mayer’s hematoxylin. After rinsed with distilled water, slides were dehydrated through an ethanol series, cleared in xylene, and covered with slips for microscopy. ALP activity assay 2 The cells of identical numbers were seeded. Cells cultured on the substrates were washed twice with PBS and fixed in 4% (v/v) paraformaldehyde for 5 min at room temperature, then incubated for 10 min with the staining solution including 0.1% (w/v) naphthol AS_MX phosphate, 56 mmol/L 2-amino-2-methyl-1-3-propanediol, and 0.1% (w/v) fast red violet LB salt, finally washed with distilled water and kept in water for 20 min. Staining solutions were freshly prepared before use. Quantitative analysis of ALP activity was determined by colorimetric assay of enzyme activity using the ALP kit (BioAssay System, USA), following the manufacturer’s instructions. Before cell dissolving, cell layers were washed three times with PBS, and then total proteins were extracted by Protein Extract Reagents (Pierce, USA), followed by centrifugation to remove cellular debris. 100 μl of lysate was then mixed with 100 μl of the freshly prepared colorimetric substrate para-nitrophenyl phosphate, and incubated at 37 °C for 30 min. The enzymatic reaction was stopped by adding 100 μl of 0.2 mol/L NaOH. The optical density of the yellow product para-nitrophenol was determined by a HTS 7000 Plus Bio Assay reader (Perkin Elmer Life Sciences, USA) at a wavelength of 405 nm. The protein concentration of the cell lysate was measured with a bicinchoninic acid (BCA) Protein Assay Kit (Pierce, USA) and the ALP activity was then expressed as OD 405 per mg protein. Mineralization nodule staining 2 The mineralization nodules formed after osteogenic induction or plasmid transfection were stained with alizarin red S (AR-S). The cells on slides were rinsed in PBS and incubated with 40 mmol/L AR-S (pH 4.2) with rotation for 30 min. Then they were rinsed 5 times with water followed by a 15 min washing with PBS by rotation to reduce nonspecific AR-S staining. The stained nodules were observed through a microscope. Statistical analysis 2 Results were expressed as mean± SD and analyzed by a paired analysis of variance. P values were described in figures and P < 0.05 was considered as statistically significant. RESULTS 1 Culture and identification of MSCs 2 Human bone marrow MSCs were isolated from bone marrow tissue and cultured at 37 °C in humidified atmosphere with 5% CO 2 . After primarily cultured for 5 d, individual colonies formed. Twelve days later, 80% confluence of cells was achieved, and then the cells were trypsinized and passaged approximately every 5~7 d for 12 passages. During the culture period, primary or passaged MSCs displayed fibroblast-like morphological features, without visible morphologic alteration. The multi-linage differentiation of cultured MSCs was confirmed when these cells have the ability of osteogenic, chondrogenic, and adipogenic potential (Fig. 1 1 in page 362). Identification of pcDNA3.1(+)/CTGF 2 According to the background reference of human CTGF cDNA record by GenBank and the trait of the designed specific primers, the whole length of PCR product fragments identified by agarose gel electrophoresis was consisted with the analysis of background reference (Fig. 2a 2a ). There were two fragments of 5.4 and 1.05 kb when pcDNA3.1(+)/CTGF was digested by Hin dIII and Xho I and electrophoresed on agarose gel. The fragment of 5.4 kb was accorded with pcDNA3.1(+), another fragment of 1.05 kb was accorded with human CTGF cDNA fragment produced by RT-PCR. These results demonstrate that CTGF cDNA has been inserted into pcDNA3.1(+)/CTGF (Fig. 2b 2b ). The DNA sequence analysis confirmed that positively reformed plasmid contains the full length of human CTGF cDNA, which is the same as the one described in the GenBank with accession No. NM_001901. The CTGF cDNA fragment containing entire coding region (corresponding to the 1.05 kb covering from the AUG start codon to the UGA stop codon) was placed downstream of the CMV promoter element. The eukaryotic expression vector pCTGF has been constructed successfully. (a) Agarose gel electrophoresis assay of CTGF PCR products. Lane 1: DNA marker, DL2000; Lane 2: CTGF (1.05 kb); (b) Digestion assay of pCTGF with Xba I and Hin dIII. Lane 1: DNA marker, DL2000; Lane 2: pCTGF Expression of CTGF in MSCs by DNA transfection 2 Real-time PCR and Western blotting analysis confirmed that pCTGF-MSCs overexpressed CTGF when compared with mock-MSCs and normal control cells (Fig. 3a 3a ). The expression of CTGF mRNA was 3.7-fold higher than those of mock-MSCs and normal control. The cell culture supernatant after 48 h post-transfection was used for Western blotting. CTGF peptide was detectable in the cell culture supernatant of pCTGF-MSCs. However, the expression of CTGF peptide was not detectable in vector control and normal control (Fig. 3b 3b ). It was suggested that CTGF was expressed effectively in the cells transfected with pCTGF. (a) The expression of CTGF mRNA of pCTGF-MSCs, mock-MSCs, and normal control cells. The amount of real-time PCR product in mock-MSCs was taken as 1.0, and the relative ratio of the products is indicated in the ordinate. The value was corrected using the expression of GAPDH as internal control. * P < 0.05, significantly different from mock-MSCs and normal cells; (b) The expression of CTGF peptide of pCTGF-MSCs, mock-MSCs, and normal control cells. In the cell supernatant from pCTGF-MSCs, a large amount of CTGF protein with an apparent molecular mass of 38 kDa was illustrated. However, the expression of CTGF peptide was not detectable in vector control and normal control Proliferation of MSCs promoted by pCTGF 2 MTT assays were performed to evaluate the proliferative abilities of pCTGF-MSCs, mock-MSCs, and normal control MSCs. As shown in Fig. 4 4 , proliferation rate of pCTGF-MSCs was significantly higher than those of mock-transfected cells and normal control cells ( P < 0.05). * P < 0.05, compared with mock-transfected cells and normal control cells Migration of MSCs promoted by pCTGF transfection 2 The transwell chamber assay is one of the frequently used methods to evaluate cell adhesion and migration in vitro. Here we conducted transwell chamber experiment to investigate whether pCTGF transfection exerted any effect on the migration of MSCs. As shown in Fig. 5c 5c (in page 362), cells that were cocultured with CTGF-expressing MSCs migrated to the underside of the membrane of the upper chamber were more than those cocultured with control cells. This indicates that CTGF secreted from pCTGF-MSCs showed a strong ability to induce the migration of the MSCs in the upper chamber as compared with normal controls. CTGF induced a 7.5-fold increase in cell migration over the empty vector-transfected controls (Fig. 5d 5d ), which was significantly higher than those cocultured with vector control and normal control ( P < 0.05). These findings suggest that pCTGF transfection could indeed promote the migration of MSCs, a potentially important feature of CTGF functions in osteoblast differentiation. Morphologic changes of MSCs caused by pCTGF transfection 2 Normal MSCs and mock-MSCs maintained a fibroblasts-like appearance with a spindle shape at confluent (Fig. 6 6 in page 362). At the same time, pCTGF-MSCs exhibited obvious morphological alteration after 2 weeks, becoming columnar and polarized, tending to align in straight parallel lines, all of which were typical morphologic features of osteoblast-like cells (Fig. 6c 6c ). These cells were very much in appearance like MSCs cultured in OS-medium (Fig. 6d 6d ). Expression patterns of bone-related genes 2 We focused on the expression of a set of genes related to bone development and mineralization in both pCTGF-MSCs and MSCs cultured in OS-medium. Expressions of osteoblastic marker genes including transcription factor Runx2, collagen type I (ColI), bone sialoprotein (BSP), and OCN in cells were analysized by real-time PCR on Days 3 and 14 after MSCs transfected with pCTGF or OS-induction. Overexpression of CTGF induced the expressions of Runx2, ColI, BSP, and OCN (Fig. 7 7 ). Similar to pCTGF-MSCs, bone-related genes were also expressed in OS-medium–induced MSCs. However, mock-MSCs and normal control MSCs only had basal expressions of these osteoblastic phenotype genes. GAPDH was used as internal control. For Runx2, collagen I (colI) and bone sialoprotein (BSP) (Days 3 and 14) and osteocalcin (OCN) (Day 14), the increased expression on pCTGF-MSCs or MSCs cultured in OS-medium was observed. However, mock-MSCs and normal control MSCs only have basal expressions of these osteoblastic phenotype genes. GAPDH was used as internal control. * P < 0.05, statistically significant difference between control cells and pCTGF-MSCs or MSCs cultured in OS-medium ALP activity in MSCs 2 We analyzed whether overexpression of CTGF could increase ALP activity in MSCs. Our data indicate that pCTGF-MSCs exhibited a linear increase in ALP activity within the first two weeks in selective medium. The levels of ALP activities of pCTGF-sMSCs at the 1st and 2nd weeks were 4.0- and 3.0-fold higher than those of MSCs cultured in OS-medium, respectively. In contrast, ALP activities of mock-MSCs and normal control MSCs remained at background levels when cultured in control medium for up to two weeks (Fig. 8 8 in page 362). Immunohistochemical analysis of the expression of OCN 2 Immunohistochemical staining was performed to detect the expression of OCN in pCTGF-MSCs, OS-induced MSCs, mock-MSCs, and normal control MSCs. As shown in Fig. 9 9 (in page 363), almost all of pCTGF-MSCs and OS-induced MSCs were positive with immunocytochemical staining. As negative control, normal control cells and mock-MSCs showed no apparent expression of OCN, when cultured under the same conditions as pCTGF-MSCs. Mineralized nodule formation 2 Alizarin red staining was performed to investigate whether the expression of bone-related genes resulted in a mineralized nodule formation. For pCTGF-MSCs, the mineralized nodules formed on Day 14 after confluence demonstrated positive AR-S staining (Figs. 10a~10b 10a~10b in page 363). For MSCs cultured in OS-medium, mineralized nodules appeared two weeks later after confluence (Fig. 10c 10c ), and these nodules were also positive with alizarin red staining (Fig. 10d 10d ). On the other hand, mock-MSCs and normal control MSCs could not form any mineralized nodules in the control medium even three weeks later after confluence (Figs. 10e~10f 10e~10f ). DISCUSSION 1 MSCs are considered as a readily accepted source of stem cells in bone tissue regeneration because they are easy to be isolated and expanded in vitro. It is still a challenge to enhance the proliferation and differentiation of seed cells in the application of bone tissue engineering, and this problem can be solved by gene therapy approaches (van Damme et al., 2002 2002 ; Gamradt and Lieberman, 2004 2004 ; Chan et al., 2005 2005 ; Betz et al., 2008 2008 ). A number of signaling molecules have been shown to participate in MSCs osteogenesis. These signaling molecules include bone morphogenetic proteins (BMPs), WNT, and FGF families, transcription factors of Runx2 and sox9 (Oakes and Lieberman, 2000 2000 ; Alden et al., 2002 2002 ; Gersbach et al., 2006 2006 ). Former studies have shown that cells of the osteoblastic lineage express transcripts for CTGF and other members of the CCN family (Arnott et al., 2007 2007 ; Edgar et al., 2007 2007 ). However, the function of CTGF in skeletal cells has been controversial, and both stimulatory and inhibitory effects on osteoblastogenesis have been reported (Abreu et al., 2002 2002 ; Luo et al., 2004 2004 ). In present study, we demonstrate that the constitutive overexpression of CTGF enhanced the osteoblastic lineage differentiation of MSCs. CTGF overexpression induced the formation of mineralized nodules, ALP, and osteocalcin expression in MSCs. On the crucial function of CTGF, we reported the osteoblastic differentiation of MSCs initiated by CTGF overexpression. We found that transfection of cDNA encoding the human CTGF in MSCs induced these cells to differentiate into functional osteoblasts with definite morphological alterations, which were also observed in MSCs cultured in OS-medium. Our data also indicate that these osteoblasts-like cells derived from pCTGF-MSCs showed high levels of ALP activity, and well-defined mineralized nodules formed just like MSCs cultured in OS-medium. Expression of several bone-related genes confirmed pCTGF-MSCs differentiated toward osteoblasts. pCTGF-transfected MSCs had the ability to express BSP, OCN, osteopontin (OPN), and colI, which are responsible for the deposition and maturation of bone extracellular matrix. Runx2, the earliest transcription factor proven essential for commitment to osteoblastogenesis, which is essential for the expression of a number of bone-specific genes, is primarily considered a master regulator of bone development. BSP is a member of the SIBLING gene family of glycoproteins involved in the formation of mineral crystal in calcified dentin and bone matrix. Expression of BSP is restricted to bone and other mineralized tissues. On the other hand, OCN is produced by mature osteoblasts during mineralization and is the one of the most abundant noncollagenous proteins both in mineralized dentin and bone extracellular matrix. ALP is the most often used early marker of osteoblast differentiation. As demonstrated in this study, ALP activity was up-regulated in CTGF-transfected MSCs. The coexpression of these genes, together with the characteristic morphological and polarization changes, suggests the differentiation of the CTGF-transfected MSCs into osteoblasts. Similarly to our results, CTGF had been proved to enhance the differentiation and function of osteoblast-like Saos-2 cells, MC3T3-E1 cells, and primary osteoblast cultures (Nishida et al., 2000 2000 ; Abreu et al., 2002 2002 ; Ivkovic et al., 2003 2003 ; Safadi et al., 2003 2003 ; Kawaki et al., 2008 2008 ; Ono et al., 2008 2008 ). In contrast, CTGF overexpression did not promote osteoblastic differentiation or mineralization in fibroblasts NIH3T3 cell line. Transduction of C3H10T1/2 mesenchymal cells with adenoviral vectors for the constitutive expression of CTGF or addition of CTGF to these cells results in impaired osteoblastogenesis, which suggests that the promotion of osteogenic differentiation was specific in multipotent stem cells or cells of osteoblastic lineage (Luo et al., 2004 2004 ; Liu et al., 2007 2007 ). The different effects of CTGF on cells of the osteoblastic lineage may reflect the fact that different mechanisms may be operational in the various cells. It has been reported that overexpression of BMP-2 inhibited the growth of a cell line derived from rat osteosarcoma, though it promoted their osteogenic differentiation (Huang et al., 2002 2002 ). Other reports also indicated that proliferative abilities of osteoblasts and MSCs are influenced by osteogenic induction (Lee et al., 2004 2004 ; Igarashi et al., 2004 2004 ; Cho et al., 2005 2005 ). It is generally believed that osteogenic induction on pluripotent cells with gene therapy approaches or chemical inducement decreases their proliferation rate. However, our results in this study show that CTGF overexpression obviously increased the proliferation rate of MSCs, as significant difference between CTGF-transfected MSCs and mock-MSCs was found. Overexpression of CTGF increases the migration of MSCs. These findings are profound in the possible application of hard tissue engineering with genetically modified MSCs. Although it has been also reported that overexpression of CTGF induces proliferation of BMSCs (bone marrow stromal cells) and NIH3T3 (Liu et al., 2007 2007 ; Ono et al., 2008 2008 ), genetic diversities among different cell sources maybe exist. Although the exact mechanism by which CTGF is involved in bone development and mineralization is yet not well understood, growing evidence shows the CCN family plays an important regulatory role during proliferation and differentiation in musculoskeletal cells. CTGF is a member of the CCN family of growth factors, which is related to selected BMP antagonists, such as Tsg and chordin (Brigstock, 2002 2002 ; Brigstock et al., 2003 2003 ). Previous studies have shown a direct protein-protein interaction between CTGF and BMP-2, and the similar interaction has been reported for Nov (Abreu et al., 2002 2002 ; Mercurio et al., 2004 2004 ; Rydziel et al., 2007 2007 ). However, Nov inhibits osteoblastogenesis by suppressing BMP-2 and WNT signaling and activities, whereas CTGF overexpression in vitro favors osteoblastogenesis despite a modest decrease in BMP/Smad and WNT/β-catenin signaling. Taken together, these results demonstrate that the effect of CTGF on osteoblastogenesis is independent of BMP-2 and WNT 3 signaling. In fact, previous studies have documented direct interactions between CTGF and BMP-2, and as a consequence, an inhibitory effect on osteoblastogenesis (Abreu et al., 2002 2002 ; Mercurio et al., 2004 2004 ). Although BMPs can induce the differentiation of mesenchymal cells toward the osteoblastic lineage, they have the ability to enhance the function of the osteoblasts. So the mechanism of CTGF overexpression promoting both proliferation and differentiation of MSCs may be explained by BMP and WNT independent signaling mechanism. In summary, we constructed pcDNA3.1(+)/CTGF eukaryotic expression vector successfully by molecular clone technology and demonstrated that endogenous CTGF promoted the migration, proliferation, and osteogenic differentiation of MSCs by CTGF overexpression. Transfection of CTGF-expressing plasmid induced MSCs to differentiate into functional osteoblast. Further investigation may be needed to investigate the promotion mechanism of both promoting proliferation and differentiation of MSCs. This observation concerning CTGF overexpression and function has led to the intriguing notion that CTGF may be a novel growth factor for bone tissue engineering. References JG Abreu , NI Ketpura , B Reversade , EM de Robertis . Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta . Nat Cell Biol , 2002 . 4 ( 8 ): 599 - 604 . 12134160 DOI: 10.1038/ncb826 http://doi.org/10.1038/ncb826 . Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta TD Alden , P Varady , DF Kallmes , JAJr Jane , GA Helm . Bone morphogenetic protein gene therapy . Spine , 2002 . 27 ( 16S ): S87 - S93 . 12205425 DOI: 10.1097/00007632-200208151-00016 http://doi.org/10.1097/00007632-200208151-00016 . Bone morphogenetic protein gene therapy JA Arnott , E Nuglozeh , MC Rico , HI Arango , PR Odgren , FF Safadi , SN Popoff . Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts . J Cell Physiol , 2007 . 210 ( 3 ): 843 - 852 . 17133352 DOI: 10.1002/jcp.20917 http://doi.org/10.1002/jcp.20917 . Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts VM Betz , OB Betz , MB Harris , MS Vrahas , CH Evans . Bone tissue engineering and repair by gene therapy . Front Biosci , 2008 . 13 ( 13 ): 833 - 841 . 17981592 DOI: 10.2741/2724 http://doi.org/10.2741/2724 . Bone tissue engineering and repair by gene therapy N Beyer Nardi , L da Silva Meirelles . Mesenchymal Stem Cells: Isolation, in Vitro Expansion and Characterization . Stem Cells. Handbook of Experimental Pharmacology , 2006 . Vol. 174 Springer Berlin Heidelberg , 249 - 282 . DOI: 10.1007/978-3-540-77855-4 http://doi.org/10.1007/978-3-540-77855-4 . Mesenchymal Stem Cells: Isolation, in Vitro Expansion and Characterization DR Brigstock . Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) . Angiogenesis , 2002 . 5 ( 3 ): 153 - 165 . 12831056 DOI: 10.1023/A:1023823803510 http://doi.org/10.1023/A:1023823803510 . Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) DR Brigstock . The CCN family: a new stimulus package . J Endocrinol , 2003 . 178 ( 2 ): 169 - 175 . 12904165 DOI: 10.1677/joe.0.1780169 http://doi.org/10.1677/joe.0.1780169 . The CCN family: a new stimulus package DR Brigstock , R Goldschmeding , KI Katsube , SC Lam , LF Lau , K Lyons , C Naus , B Perbal , B Riser , M Takigawa , 等 . Proposal for a unified CCN nomenclature . Mol Pathol , 2003 . 56 ( 2 ): 127 - 128 . 12665631 DOI: 10.1136/mp.56.2.127 http://doi.org/10.1136/mp.56.2.127 . Proposal for a unified CCN nomenclature E Caterson , L Nesti , K Danielson , R Tuan . Human marrow-derived mesenchymal progenitor cells . Mol Biotechnol , 2002 . 20 ( 3 ): 245 - 256 . 11936255 DOI: 10.1385/MB:20:3:245 http://doi.org/10.1385/MB:20:3:245 . Human marrow-derived mesenchymal progenitor cells J Chan , K O′Donoghue , J de la Fuente , IA Roberts , S Kumar , JE Morgan , NM Fisk . Human fetal mesenchymal stem cells as vehicles for gene delivery . Stem Cells , 2005 . 23 ( 1 ): 93 - 102 . 15625126 DOI: 10.1634/stemcells.2004-0138 http://doi.org/10.1634/stemcells.2004-0138 . Human fetal mesenchymal stem cells as vehicles for gene delivery HH Cho , HT Park , YJ Kim , YC Bae , KT Suh , JS Jung . Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors . J Cell Biochem , 2005 . 96 ( 3 ): 533 - 542 . 16088945 DOI: 10.1002/jcb.20544 http://doi.org/10.1002/jcb.20544 . Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors X Duan , L Yang , S Dong , R Xin , G Chen , L Guo . Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation . Archives of Orthopaedic and Trauma Surgery , 2008 . 128 ( 7 ): 751 - 759 . 18265994 DOI: 10.1007/s00402-008-0585-y http://doi.org/10.1007/s00402-008-0585-y . Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation CM Edgar , V Chakravarthy , G Barnes , S Kakar , LC Gerstenfeld , TA Einhorn . Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells . Bone , 2007 . 40 ( 5 ): 1389 - 1398 . 17303481 DOI: 10.1016/j.bone.2007.01.001 http://doi.org/10.1016/j.bone.2007.01.001 . Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells SC Gamradt , JR Lieberman . Genetic modification of stem cells to enhance bone repair . Ann Biomed Eng , 2004 . 32 ( 1 ): 136 - 147 . 14964729 DOI: 10.1023/B:ABME.0000007798.78548.b8 http://doi.org/10.1023/B:ABME.0000007798.78548.b8 . Genetic modification of stem cells to enhance bone repair CA Gersbach , JM Le Doux , RE Guldberg , AJ Garcia . Inducible regulation of Runx2-stimulated osteogenesis . Gene Ther , 2006 . 13 ( 11 ): 873 - 882 . 16496016 DOI: 10.1038/sj.gt.3302725 http://doi.org/10.1038/sj.gt.3302725 . Inducible regulation of Runx2-stimulated osteogenesis UR Goessler , K Riedel , K Hormann , F Riedel . Perspectives of gene therapy in stem cell tissue engineering . Cells Tissues Organs , 2006 . 183 ( 4 ): 169 - 179 . 17159343 DOI: 10.1159/000096508 http://doi.org/10.1159/000096508 . Perspectives of gene therapy in stem cell tissue engineering EC Heng , Y Huang , SAJr Black , PC Trackman . CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins . J Cell Biochem , 2006 . 98 ( 2 ): 409 - 420 . 16440322 DOI: 10.1002/jcb.20810 http://doi.org/10.1002/jcb.20810 . CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins D Howard , LD Buttery , KM Shakesheff , SJ Roberts . Tissue engineering: strategies, stem cells and scaffolds . J Anat , 2008 . 213 ( 1 ): 66 - 72 . 18422523 DOI: 10.1111/j.1469-7580.2008.00878.x http://doi.org/10.1111/j.1469-7580.2008.00878.x . Tissue engineering: strategies, stem cells and scaffolds W Huang , GH Rudkin , B Carlsen , K Ishida , P Ghasri , B Anvar , DT Yamaguchi , TA Miller . Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells . Exp Cell Res , 2002 . 274 ( 2 ): 226 - 234 . 11900483 DOI: 10.1006/excr.2002.5483 http://doi.org/10.1006/excr.2002.5483 . Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells M Igarashi , N Kamiya , M Hasegawa , T Kasuya , T Takahashi , M Takagi . Inductive effects of dexamethasone on the gene expression of Cbfa1, osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts . J Mol Histol , 2004 . 35 ( 1 ): 3 - 10 . 15323344 DOI: 10.1023/B:HIJO.0000020883.33256.fe http://doi.org/10.1023/B:HIJO.0000020883.33256.fe . Inductive effects of dexamethasone on the gene expression of Cbfa1, osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts S Ivkovic , BS Yoon , SN Popoff , FF Safadi , DE Libuda , RC Stephenson , A Daluiski , KM Lyons . Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development . Development , 2003 . 130 ( 12 ): 2779 - 2791 . 12736220 DOI: 10.1242/dev.00505 http://doi.org/10.1242/dev.00505 . Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development CY Jiang , C Gui , AN He , XY Hu , J Chen , Y Jiang , JA Wang . Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction . J Zhejiang Univ Sci B , 2008 . 9 ( 8 ): 630 - 637 . 18763313 DOI: 10.1631/jzus.B0820004 http://doi.org/10.1631/jzus.B0820004 . Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction RA Kanaan , M Aldwaik , OA Al-Hanbali . The role of connective tissue growth factor in skeletal growth and development . Med Sci Monit , 2006 . 12 ( 12 ): RA277 - RA281 . 17136017 . The role of connective tissue growth factor in skeletal growth and development JM Kanczler , RO Oreffo . Osteogenesis and angiogenesis: the potential for engineering bone . Eur Cell Mater , 2008 . 15 100 - 114 . 18454418 . Osteogenesis and angiogenesis: the potential for engineering bone JM Karp , TS Tanaka , R Zohar , J Sodek , MS Shoichet , JE Davies , WL Stanford . Thrombin mediated migration of osteogenic cells . Bone , 2005 . 37 ( 3 ): 337 - 348 . 15964256 DOI: 10.1016/j.bone.2005.04.022 http://doi.org/10.1016/j.bone.2005.04.022 . Thrombin mediated migration of osteogenic cells H Kawaki , S Kubota , A Suzuki , T Yamada , T Matsumura , T Mandai , M Yao , T Maeda , KM Lyons , M Takigawa . Functional requirement of CCN2 for intramembranous bone formation in embryonic mice . Biochem Biophys Res Commun , 2008 . 366 ( 2 ): 450 - 456 . 18067859 DOI: 10.1016/j.bbrc.2007.11.155 http://doi.org/10.1016/j.bbrc.2007.11.155 . Functional requirement of CCN2 for intramembranous bone formation in embryonic mice MD Kofron , CT Laurencin . Bone tissue engineering by gene delivery . Adv Drug Deliv Rev , 2006 . 58 ( 4 ): 555 - 576 . 16790291 DOI: 10.1016/j.addr.2006.03.008 http://doi.org/10.1016/j.addr.2006.03.008 . Bone tissue engineering by gene delivery S Kubota , M Takigawa . Role of CCN2/CTGF/Hcs24 in bone growth . Int Rev Cytol , 2007 . 257 1 - 41 . 17280894 DOI: 10.1016/S0074-7696(07)57001-4 http://doi.org/10.1016/S0074-7696(07)57001-4 . Role of CCN2/CTGF/Hcs24 in bone growth HS Lee , GT Huang , H Chiang , LL Chiou , MH Chen , CH Hsieh , CC Jiang . Multipotential mesenchymal ctem cells from femoral cone carrow cear the cite of osteonecrosis . Stem Cells , 2003 . 21 ( 2 ): 190 - 199 . 12634415 DOI: 10.1634/stemcells.21-2-190 http://doi.org/10.1634/stemcells.21-2-190 . Multipotential mesenchymal ctem cells from femoral cone carrow cear the cite of osteonecrosis RH Lee , B Kim , I Choi , H Kim , HS Choi , K Suh , YC Bae , JS Jung . Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue . Cell Physiol Biochem , 2004 . 14 ( 4-6 ): 311 - 324 . 15319535 DOI: 10.1159/000080341 http://doi.org/10.1159/000080341 . Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue Y Lin , E Luo , X Chen , L Liu , J Qiao , Z Yan , Z Li , W Tang , X Zheng , W Tian . Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo . J Cell Mol Med , 2005 . 9 ( 4 ): 929 - 939 . 16364200 DOI: 10.1111/j.1582-4934.2005.tb00389.x http://doi.org/10.1111/j.1582-4934.2005.tb00389.x . Molecular and cellular characterization during chondrogenic differentiation of adipose tissue-derived stromal cells in vitro and cartilage formation in vivo LD Liu , HJ Shi , L Jiang , LC Wang , SH Ma , CH Dong , JJ Wang , HL Zhao , Y Liao , QH Li . The repairing effect of a recombinant human connective-tissue growth factor in a burn-wounded rhesus-monkey ( Macaca mulatta ) model . Biotechnol Appl Biochem , 2007 . 47 ( 2 ): 105 - 112 . 17181532 DOI: 10.1042/BA20060114 http://doi.org/10.1042/BA20060114 . The repairing effect of a recombinant human connective-tissue growth factor in a burn-wounded rhesus-monkey (Macaca mulatta) model FC Luft . CCN2, the connective tissue growth factor . J Mol Med , 2008 . 86 ( 1 ): 1 - 3 . 18080105 DOI: 10.1007/s00109-007-0287-x http://doi.org/10.1007/s00109-007-0287-x . CCN2, the connective tissue growth factor Q Luo , Q Kang , W Si , W Jiang , JK Park , Y Peng , X Li , HH Luu , J Luo , AG Montag , 等 . Connective tissue growth factor (CTGF) is regulated by WNT and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells . J Biol Chem , 2004 . 279 ( 53 ): 55958 - 55968 . 15496414 DOI: 10.1074/jbc.M407810200 http://doi.org/10.1074/jbc.M407810200 . Connective tissue growth factor (CTGF) is regulated by WNT and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells JR Mauney , V Volloch , DL Kaplan . Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects . Tissue Eng , 2005 . 11 ( 5-6 ): 787 - 802 . 15998219 DOI: 10.1089/ten.2005.11.787 http://doi.org/10.1089/ten.2005.11.787 . Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects GJ Meijer , JD de Bruijn , R Koole , CA van Blitterswijk . Cell-based bone tissue engineering . PLoS Med , 2007 . 4 ( 2 ): e9 17311467 DOI: 10.1371/journal.pmed.0040009 http://doi.org/10.1371/journal.pmed.0040009 . Cell-based bone tissue engineering S Mercurio , B Latinkic , N Itasaki , R Krumlauf , JC Smith . Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex . Development , 2004 . 131 ( 9 ): 2137 - 2147 . 15105373 DOI: 10.1242/dev.01045 http://doi.org/10.1242/dev.01045 . Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex T Nishida , T Nakanishi , M Asano , T Shimo , M Takigawa . Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro . J Cell Physiol , 2000 . 184 ( 2 ): 197 - 206 . 10867644 DOI: 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R http://doi.org/10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R . Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro T Nishida , H Kawaki , RM Baxter , RA Deyoung , M Takigawa , KM Lyons . CCN2 (connective cissue crowth cactor) is essential for extracellular matrix production and integrin signaling in chondrocytes . J Cell Commun Signal , 2007 . 1 ( 1 ): 45 - 58 . 18481209 DOI: 10.1007/s12079-007-0005-z http://doi.org/10.1007/s12079-007-0005-z . CCN2 (connective cissue crowth cactor) is essential for extracellular matrix production and integrin signaling in chondrocytes DA Oakes , JR Lieberman . Osteoinductive applications of regional gene therapy: ex vivo gene transfer . Clin Orthop Relat Res , 2000 . 379 ( Suppl. ): S101 - S112 . 11039758 DOI: 10.1097/00003086-200010001-00014 http://doi.org/10.1097/00003086-200010001-00014 . Osteoinductive applications of regional gene therapy: ex vivo gene transfer M Ono , S Kubota , T Fujisawa , W Sonoyama , H Kawaki , K Akiyama , M Oshima , T Nishida , Y Yoshida , K Suzuki , 等 . Promotion of attachment of human bone marrow stromal cells by CCN2 . Biochem Biophys Res Commun , 2007 . 357 ( 1 ): 20 - 25 . 17399683 DOI: 10.1016/j.bbrc.2007.03.052 http://doi.org/10.1016/j.bbrc.2007.03.052 . Promotion of attachment of human bone marrow stromal cells by CCN2 M Ono , S Kubota , T Fujisawa , W Sonoyama , H Kawaki , K Akiyama , K Shimono , M Oshima , T Nishida , Y Yoshida , 等 . Promotion of hydroxyapatite-associated, stem cell-based bone regeneration by CCN2 . Cell Transplant , 2008 . 17 ( 1-2 ): 231 - 240 . 18468254 DOI: 10.3727/000000008783907143 http://doi.org/10.3727/000000008783907143 . Promotion of hydroxyapatite-associated, stem cell-based bone regeneration by CCN2 GG Pelled , G Turgeman , H Aslan , Z Gazit , D Gazit . Mesenchymal stem cells for bone gene therapy and tissue engineering . Curr Pharm Des , 2002 . 8 ( 21 ): 1917 - 1928 . 12171527 DOI: 10.2174/1381612023393666 http://doi.org/10.2174/1381612023393666 . Mesenchymal stem cells for bone gene therapy and tissue engineering B Perbal , DR Brigstock , LF Lau . Report on the second international workshop on the CCN family of genes . Mol Pathol , 2003 . 56 ( 2 ): 80 - 85 . 12665625 DOI: 10.1136/mp.56.2.80 http://doi.org/10.1136/mp.56.2.80 . Report on the second international workshop on the CCN family of genes I Pountos , D Corscadden , P Emery , PV Giannoudis . Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application . Injury , 2007 . 38 ( S4 ): 23 - 33 . DOI: 10.1016/S0020-1383(08)70006-8 http://doi.org/10.1016/S0020-1383(08)70006-8 . Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application AW Rachfal , DR Brigstock . Structural and functional properties of CCN proteins . Vitam Horm , 2005 . 70 69 - 103 . 15727802 DOI: 10.1016/S0083-6729(05)70003-0 http://doi.org/10.1016/S0083-6729(05)70003-0 . Structural and functional properties of CCN proteins FR Rose , RO Oreffo . Bone tissue engineering: hope vs hype . Biochem Biophys Res Commun , 2002 . 292 ( 1 ): 1 - 7 . 11890663 DOI: 10.1006/bbrc.2002.6519 http://doi.org/10.1006/bbrc.2002.6519 . Bone tissue engineering: hope vs hype S Rydziel , L Stadmeyer , S Zanotti , D Durant , A Smerdel-Ramoya , E Canalis . Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia . J Biol Chem , 2007 . 282 ( 27 ): 19762 - 19772 . 17500060 DOI: 10.1074/jbc.M700212200 http://doi.org/10.1074/jbc.M700212200 . Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia FF Safadi , J Xu , SL Smock , RA Kanaan , AH Selim , PR Odgren , SCJr Marks , TA Owen , SN Popoff . Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo . J Cell Physiol , 2003 . 196 ( 1 ): 51 - 62 . 12767040 DOI: 10.1002/jcp.10319 http://doi.org/10.1002/jcp.10319 . Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo BJ Slater , MD Kwan , DM Gupta , NJ Panetta , MT Longaker . Mesenchymal cells for skeletal tissue engineering . Expert Opin Biol Ther , 2008 . 8 ( 7 ): 885 - 893 . 18549320 DOI: 10.1517/14712598.8.7.885 http://doi.org/10.1517/14712598.8.7.885 . Mesenchymal cells for skeletal tissue engineering A van Damme , T van den Driessche , D Collen , MK Chuah . Bone marrow stromal cells as targets for gene therapy . Curr Gene Ther , 2002 . 2 ( 2 ): 195 - 209 . 12109216 DOI: 10.2174/1566523024605645 http://doi.org/10.2174/1566523024605645 . Bone marrow stromal cells as targets for gene therapy Y Xiang , Q Zheng , BB Jia , GP Huang , YL Xu , JF Wang , ZJ Pan . Ex vivo expansion and pluripotential differentiation of cryopreserved human bone marrow mesenchymal stem cells . J Zhejiang Univ Sci B , 2007 . 8 ( 2 ): 136 - 146 . 17266190 DOI: 10.1631/jzus.2007.B0136 http://doi.org/10.1631/jzus.2007.B0136 . Ex vivo expansion and pluripotential differentiation of cryopreserved human bone marrow mesenchymal stem cells T Yamaai , T Nakanishi , M Asano , K Nawachi , G Yoshimichi , K Ohyama , T Komori , T Sugimoto , M Takigawa . Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development . J Bone Miner Metab , 2005 . 23 ( 4 ): 280 - 288 . 15981023 DOI: 10.1007/s00774-004-0600-5 http://doi.org/10.1007/s00774-004-0600-5 . Gene expression of connective tissue growth factor (CTGF/CCN2) in calcifying tissues of normal and cbfa1-null mutant mice in late stage of embryonic development O Yamanaka , S Saika , K Ikeda , K Miyazaki , A Kitano , Y Ohnishi . Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro . Jpn J Ophthalmol , 2008 . 52 ( 1 ): 8 - 15 . 18369694 DOI: 10.1007/s10384-007-0497-3 http://doi.org/10.1007/s10384-007-0497-3 . Connective tissue growth factor modulates extracellular matrix production in human subconjunctival fibroblasts and their proliferation and migration in vitro We are grateful to Prof. Tong-chuan He (Molecular Oncology Laboratory, University of Chicago Medical Center, USA) for kindly providing the plasmid containing full-length CTGF cDNA fragment. We are also grateful for the contributions of many people within the Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, China. Special thanks must also go to Prof. Xiao-feng Lu (Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, China) and Dr. Yan-bao Li (College of Materials Science and Engineering, Nanjing University of Technology, China) for helpful discussion. 10.1631/jzus.B0820252 Project supported by the National Basic Research Program (973) of China (No. 2005CB623900) 2008-08-18 2009-03-25 2009-01-19 2022-01-05 Copyright © 2009, Journal of Zhejiang University Science 2009 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 05 10